8-K - PFIZER INC (0000078003) (Filer)
Published . Updated .
Key takeaways
- 8-K - PFIZER filed an 8-K with the SEC on Nov 3 (a notice of a material company event).
- Exposed: PFE
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - PFIZER filed an 8-K with the SEC on Nov 3 (a notice of a material company event).
Directly affected
- PFE Pfizer+9.0% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Pfizer belongs to, so it often moves with news about it.
- LLY Eli Lilly and+20.6% 30d
Eli Lilly and is a peer of Pfizer in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+0.5% 30d
Johnson & Johnson is a peer of Pfizer in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+8.9% 30d
AbbVie is a peer of Pfizer in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+3.3% 18d
Merck is a peer of Pfizer in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+8.1% 30d
Abbott Laboratories is a peer of Pfizer in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| PFE | -1.47% | +1.94% | base | after close | after close | after close | after close |
| XLV | -2.31% | +0.48% | base | after close | after close | after close | after close |
| LLY | -8.25% | +0.73% | base | after close | after close | after close | after close |
| JNJ | +2.19% | +2.93% | base | after close | after close | after close | after close |
| ABBV | +0.42% | +3.41% | base | after close | after close | after close | after close |
| MRK | -1.72% | +4.16% | base | after close | after close | after close | after close |
| ABT | -5.79% | -2.52% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-03 AccNo: 0000078003-26-000132 Size: 244 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial St…
Source: sec-edgar
Pfizer (PFE) since “8-K - PFIZER INC (0000078003) (Filer),” compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | three days earlier | +3.41% | final price |
| ABBV | five days earlier | +0.42% | final price |
| ABT | three days earlier | -2.52% | final price |
| ABT | five days earlier | -5.79% | final price |
| JNJ | three days earlier | +2.93% | final price |
| JNJ | five days earlier | +2.19% | final price |
| LLY | three days earlier | +0.73% | final price |
| LLY | five days earlier | -8.25% | final price |
| MRK | three days earlier | +4.16% | final price |
| MRK | five days earlier | -1.72% | final price |
| Pfizer (PFE) | three days earlier | +1.94% | final price |
| Pfizer (PFE) | five days earlier | -1.47% | final price |
| XLV | three days earlier | +0.48% | final price |
| XLV | five days earlier | -2.31% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 74 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 34 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 56 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 50 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 76 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 32 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 46 days before publication. Filed 12 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Pfizer (PFE)
Companies tied to this story
- PFE Pfizer
In “8-K - PFIZER INC (0000078003) (Filer),” Pfizer (PFE) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> PFE
How “8-K - PFIZER INC (0000078003) (Filer)” reaches Pfizer (PFE)
Pfizer (PFE) is the company in “8-K - PFIZER INC (0000078003) (Filer),” the 3 Nov 2026 this story story.
For Pfizer (PFE), the reason on file says SEC 8-K filing -> direct issuer disclosure -> PFE
The price range for Pfizer (PFE), and the dates in the story
PFE traded between 27.48 and 31.04 across 20 sessions. The latest close on file is 30.71.
How strong the case is around Pfizer (PFE)
14 out of 100
“8-K - PFIZER INC (0000078003) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.